ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
2,696
Screening encounters
3,005
Diagnostic referrals
587
Outstanding pathways
233

Screening pathway

  1. Screening3,005Encounters
  2. Positive finding1,027Documented findings
  3. Referral587Diagnostic referrals
  4. Follow-up661Diagnostic visits
  5. Outcome354Resolved pathways

Stage totals use different units. Pending pathways: 233. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 4792 · EXP-4792Synthetic · Site B

Full participant history through 2026-04-26, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-04-06
  4. · Diagnostic referral · EXP-4792-T-R
  5. · Contact attempt · Reached
  6. · Diagnostic booking · Initial booking
  7. · Diagnostic visit · Attended
  8. · Diagnosis · Colposcopy · Biopsy collected
  9. · Diagnosis · Histopathology · No high-grade lesion identified
  10. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2026-12-05
  11. · Follow-up disposition · Resolved · EXP-4792-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

2696 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-2761 · Expanded synthetic participant 2761Site E — Resource-Constrained Navigation Programme
EXP-2763 · Expanded synthetic participant 2763Site B — Peri-Urban Access Programme
EXP-2766 · Expanded synthetic participant 2766Site B — Peri-Urban Access Programme
EXP-2767 · Expanded synthetic participant 2767Site B — Peri-Urban Access Programme
EXP-2770 · Expanded synthetic participant 2770Site C — Rural Outreach Programme
EXP-2771 · Expanded synthetic participant 2771Site B — Peri-Urban Access Programme
EXP-2772 · Expanded synthetic participant 2772Site E — Resource-Constrained Navigation Programme
EXP-2773 · Expanded synthetic participant 2773Site E — Resource-Constrained Navigation Programme
EXP-2775 · Expanded synthetic participant 2775Site B — Peri-Urban Access Programme
EXP-2778 · Expanded synthetic participant 2778Site D — Community Engagement Programme
EXP-2780 · Expanded synthetic participant 2780Site D — Community Engagement Programme
EXP-2781 · Expanded synthetic participant 2781Site C — Rural Outreach Programme
EXP-2783 · Expanded synthetic participant 2783Site C — Rural Outreach Programme
EXP-2784 · Expanded synthetic participant 2784Site D — Community Engagement Programme
EXP-2785 · Expanded synthetic participant 2785Site C — Rural Outreach Programme
EXP-2786 · Expanded synthetic participant 2786Site C — Rural Outreach Programme
EXP-2790 · Expanded synthetic participant 2790Site A — Urban Referral Hub
EXP-2791 · Expanded synthetic participant 2791Site D — Community Engagement Programme
EXP-2792 · Expanded synthetic participant 2792Site A — Urban Referral Hub
EXP-2795 · Expanded synthetic participant 2795Site B — Peri-Urban Access Programme
EXP-2796 · Expanded synthetic participant 2796Site D — Community Engagement Programme
EXP-2798 · Expanded synthetic participant 2798Site C — Rural Outreach Programme
EXP-2800 · Expanded synthetic participant 2800Site D — Community Engagement Programme
EXP-2801 · Expanded synthetic participant 2801Site A — Urban Referral Hub
EXP-2803 · Expanded synthetic participant 2803Site D — Community Engagement Programme

Programme insights

Encounters by modality

VIA
1238
HPV DNA
1320
Cytology
447

Navigation activity

Barrier documented
495
Contact attempt
857
Navigation intervention
213
Diagnostic booking
719
Diagnostic visit
661

Documented barriers

Contact difficulty
161
Transport difficulty
151
Appointment coordination
183

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.